5 min read
2 min read
Meet Veristat at Clinical Outsourcing Group - Bay Area 2025
Strategic from the Start: Leveraging Your CRO as a True Development Partner
Veristat is excited to participate in the Clinical Outsourcing Group - Bay Area conference, taking place October 21-22, 2025. This premier gathering of biotech leaders and clinical outsourcing professionals provides the perfect forum to address a critical industry challenge: why most CRO relationships still fall short of true strategic partnership.
Our Presentation: Hard Conversations That Drive Success
Join our session "Strategic from the Start: Leveraging Your CRO as a True Development Partner" on October 21 at 4:45pm where we'll explore why clinical outsourcing should evolve beyond transactional services, but often doesn't. We'll share real-world examples of how early, integrated collaboration helps sponsors navigate the full development lifecycle, from funding to first patient, and through regulatory approval.
What makes this session different? We'll discuss the uncomfortable realities most CROs avoid: unrealistic timelines, flawed study designs, and regulatory blind spots that derail approvals. You'll hear directly from a client partner who experienced this model of honest collaboration firsthand, offering practical insights into how strategic partnerships actually work.
Speaker Bios:
Patrick Flanagan
Chief Executive Officer, Veristat
Patrick Flanagan serves as Chief Executive Officer of Veristat, where he leads the company’s strategy, business operations and financial performance. With a distinguished career spanning consulting, healthcare and software sectors, Patrick has successfully driven commercial growth and international expansion while making significant contributions to global healthcare. Prior to joining Veristat in 2013, he held leadership positions at organizations including A.T. Kearney, Baxter International and Oracle.
.png?width=768&height=768&name=hyun-3-768x768%20(1).png)
Hyun Kim
Senior Vice President of Clinical Development, AOBiome
Hyun has been a part of AOBiome’s clinical pipeline leadership since 2016. Taking charge of our latest Phase II Trial, Hyun brings over 20 years of drug development experience in the pharma and biotech industry. Prior to this, Hyun has led Clinical and R&D programs and departments at Pfizer, Anika Therapeutics, Transport Pharmaceuticals, and Olympus Biotech. He started his career at Genetics Institute and Wyeth, where he developed biologics for tissue repair. He attended Brown University where he studied Biomedical Engineering and completed a PhD in Medical Science.
Why This Conversation Matters
Traditional CRO relationships focus on telling sponsors what they want to hear. Strategic partnerships focus on what sponsors need to hear. The difference determines whether your program achieves regulatory success or becomes an expensive lesson.
At Veristat, we've built our reputation on delivering the partnership you actually need, not just the one you think you want. Our approach combines:
-
Early Integration: CRO involvement from program conceptualization, not just protocol execution
-
Shared Risk Mitigation: Joint accountability for program outcomes and regulatory success
-
Regulatory Foresight: Agency-thinking expertise that prevents surprises and costly delays
-
Honest Communication: Hard conversations that protect your program from predictable setbacks
Visit Our Booth
Stop by our booth to explore what true strategic partnership looks like. We'll be sharing examples of difficult conversations that saved programs, regulatory challenges that required honest assessments, and success metrics that go beyond deliverable completion to focus on approval outcomes.
Ready for an honest conversation about your development challenges? Our team will be available to discuss how strategic partnership can accelerate your path to regulatory success, even when that conversation includes uncomfortable realities about what's not working in your current approach.
Connect With Our Experts
Our clinical development and regulatory affairs leaders will be on-site to discuss your specific program needs and share insights from our extensive experience guiding biotech sponsors through complex regulatory pathways. Whether you're planning your first clinical trial or navigating late-stage development challenges, we're prepared to have the strategic conversations that actually matter for your program success.
Conference Details:
-
Date: October 21-22, 2025
-
Location: Bay Area
-
Visit: Our booth for strategic partnership discussions
-
Attend: Our presentation on October 21 at 4:45pm
Contact us to schedule a meeting or learn more about how Veristat's strategic partnership approach can transform your clinical development program